are not likely to die from an atypical nevus. Q: About 60 years ago, my friend died from multiple sclerosis.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
MULTIPLE SCLEROSIS
Multiple sclerosis (MS) is an autoimmune condition that attacks the central nervous system. This topic tracks information on multiple sclerosis treatments and the financial impact on companies researching and developing new drugs to fight this terrible disease.
Multiple Sclerosis is part of Business Exchange, suggested by
Steve McCarthy.
This topic contains
967 news
and
242 blog
items.
Read updated news, blogs, and resources about Multiple Sclerosis. Find user-submitted articles and reactions on Multiple Sclerosis from
like-minded professionals.
News
Please add new articles to this topic
Phase III ALLEGRO study of laquinimod, an investigational, oral, once- daily, immunomodulator for the treatment of...
Biogen Idec Inc.'s oral drug for multiple sclerosis showed success in the first of two large clinical trials, moving...
A Phase 3 trial of Biogen Idec Inc.���s multiple sclerosis treatment BG-12 met the primary endpoint of reducing the...
Medical Systems surged 32% to $29.55 in premarket trading. A Phase 3 trial of Biogen Idec���s multiple sclerosis...
the world to know, Tom Selleck is a very sexy man.Rappaport is also a 73-year-old living with multiple sclerosis, a...
a portfolio hedge. Biogen Idec Inc. rallied 5.2 percent to $77.07. The worlds largest maker of multiple sclerosis...
Biogen Idec's experimental multiple sclerosis drug met the main goal in the first of two important late-stage studies,...
percent amid optimism the drug, if approved will strengthen Biogen's position in the highly competitive market for...
chronic illnesses are facing fewer sessions and longer waiting times Patients with chronic illnesses such as cystic...
treatment called reaZin, which treats symptoms of Alzheimer���s disease, and a drug called Trimesta, for treatment of...
on. She has said that she wants to focus on the health of her husband, who has battled multiple sclerosis and cancer,...
the Phase III ALLEGRO study of laquinimod, an investigational, oral, once-daily, immunomodulator for the treatment of...
Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that new data from the company's multiple...
in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its...
EDT NEW YORK (Reuters Health) - A new research review strengthens the evidence that women with multiple sclerosis are...
The label of multiple sclerosis drug Tysabri, sold by Biogen Idec Inc. and Elan Corp., has been changed to include the...
investors earlier this week when the company said paid prescriptions had more than doubled for Acthar Gel, its multiple...
that it will present new data from its completed Phase 2 trial of the investigational drug alemtuzumab for multiple...
rising 19.6 percent last year. Express Scripts estimated that specialty drugs -- including treatments for inflammatory...
entering pivotal phase are laquinimod, an orally administered small molecule with unique immunomodulatory properties...
a leukemia drug that brought in $4.3 billion, may face generic competition starting in 2015. The oral multiple...
a leukemia drug that brought in $4.3 billion, may face generic competition starting in 2015. The oral multiple...
Our ex-colleague and friend Karen Dust, who has died aged 48 after suffering from a progressive form of multiple...
by medical professionals. Express Scripts said 68 percent of specialty drug costs were on treatments for inflammatory...
Top Sources: Multiple Sclerosis
- St. Petersburg Times
- Reuters
- Chicago Tribune
- Mail Online UK
- MarketWatch
- BBC
- Boston Globe
- Philadelphia Inquirer
- BusinessWeek
- Seattle Times
account